Related Experiment Videos

Leukocyte-induced endothelial dysfunction in the rabbit basilar artery: modulation by platelet-activating factor

S E Akopov1, R Sercombe, J Seylaz

  • 1Laboratoire de Recherches Cérébrovasculaires, CNRS UA 641, Université Paris VII, France.

Insights

Activated polymorphonuclear leukocytes (PMNLs) impair blood vessel relaxation. Platelet-activating factor (PAF) enhances PMNL activation, leading to greater endothelial dysfunction and microlesions in the basilar artery.

Area of Science:

  • Vascular biology
  • Immunology
  • Endothelial function

Background:

  • Polymorphonuclear leukocytes (PMNLs) play a role in vascular inflammation.
  • Endothelial dysfunction is a key factor in cardiovascular diseases.
  • N-formyl-methionyl-leucyl-phenylalanine (fMLP) is a potent activator of PMNLs.

Purpose of the Study:

  • To investigate the impact of activated PMNLs on endothelium-dependent relaxation of the rabbit basilar artery (BA).
  • To determine the role of platelet-activating factor (PAF) in modulating PMNL-induced endothelial dysfunction.

Main Methods:

  • Isolated rabbit basilar artery (BA) segments were used in organ bath studies.
  • Endothelium-dependent relaxation was assessed using acetylcholine (ACh) and bradykinin.
  • Endothelium-independent relaxation was measured with nitroprusside.
  • PMNL activation was induced by fMLP, with or without PAF.
  • Beta-glucuronidase activity was measured to assess PMNL exocytosis.
  • Scanning electron microscopy (SEM) was used to examine endothelial morphology.

Main Results:

  • Activated PMNLs significantly reduced endothelium-dependent relaxation to ACh and bradykinin (p < 0.05).
  • PMNLs did not affect endothelium-independent relaxation to nitroprusside.
  • Low concentrations of PAF potentiated PMNL-induced inhibition of relaxation.
  • PAF enhanced PMNL exocytosis and caused more apparent endothelial microlesions.
  • PAF enabled PMNLs to induce dysfunction at lower cell concentrations and shorter contact times.

Conclusions:

  • Activated PMNLs significantly impair endothelium-dependent vasodilation.
  • Platelet-activating factor (PAF) acts as a potentiator, increasing PMNL aggression towards the endothelium.
  • PAF-mediated potentiation of PMNLs leads to exacerbated endothelial dysfunction and morphological damage.

Related Concept Videos